During the past decade, Montreal location conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montreal location" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Montreal location" are "Homozygous Familial Hypercholesterolemia (HoFH)" (2 trials). Many other conditions were trialed in "Montreal location" in a lesser frequency.

Most popular intervention types in "Montreal location" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "AAV directed hLDLR gene therapy" (1 trials) and "Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montreal location" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Montreal location". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Montreal location, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Montreal location, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".